| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Savara Inc (SVRA) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 12 sells. SVRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.53M | $14.00M | - | |
| CEO | 1.19M | $6.56M | - | |
| Other | 519.2K | $2.87M | - | |
| Other | 371.7K | $2.05M | - | |
| Dir | 300.8K | $1.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2018 | Jouhikainen Jaakko Taneli | See Remarks | Sell | 17,757 | $12.10 | $214,788.62 | -2.8% | |
| Jun 12, 2018 | Neville Robert N | Chief Executive Officer | Sale+OE | 17,973 | $12.09 | $217,311.61 | -1.3% | |
| Mar 29, 2018 | Pikover Yuri | Director | Buy | 3,734 | $9.00 | $33,603.01 | +2.5% | |
| Feb 15, 2018 | Neville Robert N | Chief Executive Officer | Sell | 25,000 | $12.93 | $323,173.45 | -3.0% | |
| Feb 15, 2018 | Jouhikainen Jaakko Taneli | See Remarks | Sell | 25,000 | $12.85 | $321,319.67 | -5.5% | |
| Feb 15, 2018 | Lowrance David L47 | Chief Financial Officer | Sale+OE | 7,000 | $12.88 | $90,129.44 | -12.4% | |
| Oct 27, 2017 | Pikover Yuri | Director | Buy | 50,000 | $7.85 | $392,500.00 | +50.0% | |
| Jun 7, 2017 | Neville Robert N | Chief Executive Officer | Buy | 52,250 | $4.75 | $248,187.50 | +13.8% | |
| Jun 7, 2017 | Jouhikainen Jaakko Taneli | See Remarks | Buy | 10,500 | $4.75 | $49,875.00 | +4.7% | |
| Jun 7, 2017 | Lowrance David L47 | Chief Financial Officer | Buy | 2,100 | $4.75 | $9,975.00 | New |